Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
60.26 USD | +0.20% | -0.10% | -27.61% |
17/05 | Cytokinetics, Incorporated Announces Resignation of Sandford D. Smith as Board of Directors | CI |
15/05 | Transcript : Cytokinetics, Incorporated - Shareholder/Analyst Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.61% | 630.59Cr | |
+9.54% | 11TCr | |
+13.14% | 11TCr | |
-6.99% | 2.22TCr | |
-1.48% | 2.13TCr | |
-4.36% | 1.88TCr | |
-6.02% | 1.75TCr | |
-39.36% | 1.72TCr | |
+6.28% | 1.41TCr | |
+34.44% | 1.22TCr |
- Stock Market
- Equities
- CYTK Stock
- News Cytokinetics, Incorporated
- Goldman Sachs Starts Coverage on Cytokinetics with Buy Rating, $50 Price Target